HOME ABOUT US SERVICES RESEARCH EQUITY DERIVATIVES IPO INTERNET TRADING FTP CONTACT US
  
SENSEX 95.15 0.39%
24270.85
 
NIFTY 261.79 0.34%
77763.91
 
Nasdaq -207.36 -0.80%
25832.67
 
Nikkei 225 1010.92 1.47%
69744.07
 
FTSE 100 26.10 0.25%
10679.00
 
YOU ARE ON
Equity
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
 
Shukra Pharmaceuticals Ltd.
 
Source DateBoard Meeting DateDetails
05-Jun-2026 10-Jun-2026 Inter alia, to consider and approve the following: - 1. Ratification of Approval for member's resolution passed in the Extra-Ordinary General Meeting dated 01tt November,2025. The Shareholders approval for the above allotment was earlier received vide Video Conferencing at Extra-Ordinary General Meeting on l't November 2025 andreceived the BSE in-principle approval for the same on 9ft January 2026 vide letter dated 9th January 2026. However, as per instructions of BSE, the Company is required to ratify the allotment, since the allotment was considered to be not completed within 15 days of receipt of in-principle approval. Hence, the Company proposes to consider the same at the forthcoming Shareholders meeting via Postal Ballot for ratification by the shareholders under regulation 170(2) of SEBI (ICDR) Regulations. 2. To approve draft of notice of postal ballot to approve the above-mentioned agenda; 3. Any other business with the permission of Chairman.
29-Apr-2026 07-May-2026 Final Dividend
06-Mar-2026 16-Mar-2026 Inter alia, to transact the following business: 1) To review the performance of Non-Independent Directors and the Board as a whole. 2) To Review the performance of the Chairman of the Company. 3) To access the Quantity, Quality and timeliness of flow of information. 4) Any other business with the permission of the chair.
30-Jan-2026 04-Feb-2026 Quarterly Results (Revised)
31-Oct-2025 13-Nov-2025 Quarterly Results
22-Sep-2025 03-Oct-2025 Inter alia to consider and approve the following: - 1. Preferential Issue of warrants as per Chapter V and in accordance with Securities arid Exchange Board of India (Issue of capital and Disclosure requirements) Regulations 2018 to Promoters subject to approval of shareholders and such other approvals as may be required under applicable laws; 2. To declare and fix relevant date for the Pproposed preferential issue. 3. fix day, date, time and venue for Extra-ordinary General meeting (EGM); 4. Appointment of scrutinizer for the process of Remote E-voting as well as voting at the EGM; 5. Any other business with the permission of Chairman,
31-Jul-2025 13-Aug-2025 Quarterly Results
02-Jun-2025 04-Jun-2025 Final Dividend
16-May-2025 29-May-2025 Audited Results
03-Feb-2025 14-Feb-2025 Quarterly Results
24-Jan-2025 29-Jan-2025 Stock Split
06-Jan-2025 09-Jan-2025 Inter alia, approving the offer and issue of equity shares of the Company by way of a rights issue to eligible shareholders of the Company as on the record date (to be decided at a later date) for an amount not exceeding Rs.36 crore in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended and other applicable laws (the "Rights Issue"). Please note that a meeting of the Right Issue Committee of the Board (?Committee?) is scheduled to be held on Thursday, January 9, 2025 inter alia, to consider, discuss and decide on various matters in connection with the Rights Issue including the specific terms such as the determination of the rights issue price and related payment mechanism, rights entitlement ratio, the record date, timing of the rights issue and other related matters.
07-Nov-2024 14-Nov-2024 Quarterly Results
23-Sep-2024 28-Sep-2024 Right Issue of Equity Shares
05-Aug-2024 12-Aug-2024 Quarterly Results
21-May-2024 29-May-2024 Audited Results & Dividend
23-Feb-2024 29-Feb-2024 Increase in Authorised Capital & Bonus issue Inter alia, to consider and approve :- 1. To consider and approve the proposal for issuance of fully paid up bonus equity shares to the members of the Company subject to necessary approval; 2. To consider and approve the proposal of increase in the authorized share capital of the Company and subsequent alteration to the Memorandum of Association of the Company. if needed, subject to necessary approval; 3. To consider and finalize the matters to be included in Notice of EGM/Postal Ballot including day, Date, Place & Time, if required;
05-Feb-2024 12-Feb-2024 Quarterly Results
27-Oct-2023 08-Nov-2023 Quarterly Results
03-Aug-2023 12-Aug-2023 Quarterly Results
Page 1 of 5
Prev || Next
 
ADINATH STOCK BROKING PVT LTD  :   SEBI REGISTRATION NUMBERS : Bombay Stock Exchange(BSE): CASH -INZ000204337 & DERIVATIVE -INZ000204337 Member ID-3175 National Stock Exchange(NSE): CASH- INZ000204337 & DERIVATIVES -INZ000204337 Member ID-12805 MCX-SX Stock Exchange(MCX-SX): Currency Derivative : INZ000204337 Member ID-44400 United Stock Exchange(USE): Currency Derivative: Central Depository Services Ltd(CDSL)- IN -DP-452/2008 DP ID 12055200
ATTENTION INVESTORS :   "Prevent unauthorised transactions in your Broking & demat account--> Update your mobile numbers/email IDs with your stock brokers & depository participate. Receive information of your transactions directly from Exchange & CDSL on your mobile/email at the end of the day......................Issued in the interest of Investors"
ATTENTION INVESTORS :   "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
ATTENTION INVESTORS :   "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
ATTENTION INVESTORS :   1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. "Issued in the interest of Investors"
| Disclaimer | Privacy Policy | Feedback | Terms and Conditions | Careers | Investor Grievances | Download | Investor Protection | SCORES | Site Map
Investor Charter - DP | Investor Charter - Stock Broker | e-voting | Investor Education | Client Collateral Details | NSDL eVoting | Advisory for investors
Useful links: NSE | BSE | MCX-SX | CDSL | SEBI | MCX | NCDEX | FMC | Smart ODR
SEBI Registration No.INZ000042629
Copyright © 2011 Adinath Stock Broking Pvt Ltd                             Designed, Developed & Content Powered By ●●● Accord Fintech Pvt.Ltd.